Trials / Unknown
UnknownNCT01204554
Microcirculation in Perforator Flaps. Enhancing Tissue Survival
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study is to assess the microcirculatory changes in the distal part of the perforator flap using ICG fluorescence angiography.
Detailed description
Perforator flaps are increasingly used in reconstructive surgery both as pedicled and free flaps, mostly because of reduced donor site morbidity and superior aesthetic result. However, the there is still much to learn about the hemodynamic changes within these flaps.The aim of the present study is to assess the microcirculatory changes in the distal part of the perforator flap using ICG fluorescence angiography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indocyanine green (ICG) | a water-soluble dye that binds to plasma proteins and remains in the intravascular space after intravenous injection.ICG has a normal plasma half life of 3-4 min. Dosage planned is 0 .5 mg/kg dose of ICG resolved in 5 % dextrose 2 mg /ml. |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-09-17
- Last updated
- 2010-09-17
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT01204554. Inclusion in this directory is not an endorsement.